IMS Health Named a Leader for Worldwide Sales and Marketing IT Outsourcing by IDC MarketScape
30 September 2015 - 11:00PM
Business Wire
Rated Highly Among All Vendors for Life
Sciences-Specific Industry Expertise and Technical Skills
IMS Health (NYSE:IMS) has been named a leader in the IDC
MarketScape: Worldwide Life Science Sales and Marketing ITO 2015
Vendor Assessment (doc # HI258425, August 2015). According to
the IDC MarketScape assessment, “Relative to other vendors
discussed in this report and based on feedback from multiple
customer references, IMS Health was rated highly for life
science-specific industry expertise and for its technical skills.…
IMS Health has experience working with life science companies
across all three sections of the industry: pharmaceutical, biotech
and medical devices.”
These strengths reflect IMS Health’s deep industry knowledge,
strong customer references and proven ability to deliver measurable
value to clients.
“Life science companies are interested in vendors with several
specific proven attributes, including: deep, proven
industry-specific expertise with a strong book of references;
willingness to provide dedicated resources on an ongoing basis
across sequential projects to maintain acquired best practices;
capability to provide onshore/onsite resources; proven
understanding of industry regulations and compliance initiatives,”
said Eric Newmark, program director of IDC Health Insights’ Life
Science Business Systems Strategy service.
The findings and vendor positions were based on detailed
surveys and interviews with the vendors, publicly available
information, and end-user experiences in an effort to provide an
accurate and consistent assessment of each vendor’s
characteristics, behaviors and capabilities. According to the
IDC MarketScape report, the definition of ITO covers several areas
including: all services surrounding system implementation; systems
and data integration; application development; various maintenance
and support functions; and infrastructure outsourcing, as well as
other types of related external IT-centric services.
“We’re very pleased with this latest recognition from IDC Health
Insights and our clients,” said Robert Chu, senior vice president,
Technology Solutions, IMS Health. “This rating reflects IMS
Health’s continued focus and investment regarding multichannel
marketing, master data management and data integration that drive
innovation and results for healthcare systems around the
world.”
An excerpt of the IDC MarketScape: Worldwide Life Science Sales
and Marketing ITO 2015 Vendor Assessment report can be viewed at
http://imshealth.com/IDCITO2015.
More information about IMS Health’s sales and marketing services
can be found at www.imshealth.com.
About IMS Health
IMS Health is a leading global information and technology
services company providing clients in the healthcare industry with
comprehensive solutions to measure and improve their performance.
End-to-end proprietary applications and configurable solutions
connect 10+ petabytes of complex healthcare data through the IMS
OneTM cloud platform, providing comprehensive insights into
diseases, treatments, costs and outcomes. The company’s 15,000
employees blend global consistency and local market knowledge
across 100 countries to help clients run their operations more
efficiently. Customers include pharmaceutical, consumer health and
medical device manufacturers and distributors, providers, payers,
government agencies, policymakers, researchers and the financial
community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes.
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an
overview of the competitive fitness of ICT (information and
communications technology) suppliers in a given market. The
research methodology utilizes a rigorous scoring methodology based
on both qualitative and quantitative criteria that results in a
single graphical illustration of each vendor’s position within a
given market. IDC MarketScape provides a clear framework in which
the product and service offerings, capabilities and strategies, and
current and future market success factors of IT and
telecommunications vendors can be meaningfully compared. The
framework also provides technology buyers with a 360-degree
assessment of the strengths and weaknesses of current and
prospective vendors.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150930005224/en/
IMS HealthTor Constantino,
+1-484-567-6732tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Jul 2023 to Jul 2024